Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial - 23/02/23
, Agnes Bangura, MSc a, b, Frank Baiden, PhD a, b, Abu Bakarr Kamara, MBChB c, Philip Ayieko, PhD a, d, Joseph Kallon, MBChB c, Julie Foster, MSc a, Musa Conteh, MBChB c, Nicholas Edward Connor, MSc a, Bockarie Koroma, BPharm Hons c, Yusupha Njie, MSc a, b, Paul Borboh, BPharm Hons c, Babajide Keshinro, FWACP e, Bolarinde Joseph Lawal, MSc a, b, Mattu Tehtor Kroma, MSc c, Godfrey Tuda Otieno, BSc a, b, Abdul Tejan Deen, BSc c, Edward Man-Lik Choi, PhD a, Ahmed Dahiru Balami, PhD a, b, Auguste Gaddah, PhD f, Chelsea McLean, PhD e, Kerstin Luhn, PhD e, Hammed Hassan Adetola, FWACP a, b, Gibrilla Fadlu Deen, FWACP c, Mohamed Samai, ProfPhD c, Brett Lowe, MSc a, Cynthia Robinson, MD e, Bailah Leigh, FWACS c, Brian Greenwood, ProfMD a, Deborah Watson-Jones, ProfPhD a, dSummary |
Background |
Children account for a substantial proportion of cases and deaths during Ebola virus disease outbreaks. We aimed to evaluate the safety and immunogenicity of a booster dose of the Ad26.ZEBOV vaccine in children who had been vaccinated with a two-dose regimen comprising Ad26.ZEBOV as dose one and MVA-BN-Filo as dose two.
Methods |
We conducted an open-label, non-randomised, phase 2 trial at one clinic in Kambia Town, Sierra Leone. Healthy children, excluding pregnant or breastfeeding girls, who had received the Ad26.ZEBOV and MVA-BN-Filo vaccine regimen in a previous study, and were aged 1–11 years at the time of their first vaccine dose, received an intramuscular injection of Ad26.ZEBOV (5 × 1010 viral particles) and were followed up for 28 days. Primary outcomes were safety (measured by adverse events) and immunogenicity (measured by Ebola virus glycoprotein-specific IgG binding antibody geometric mean concentration) of the booster vaccine dose. Safety was assessed in all participants who received the booster vaccination; immunogenicity was assessed in all participants who received the booster vaccination, had at least one evaluable sample after the booster, and had no major protocol deviations that could have influenced the immune response. This trial is registered with ClinicalTrials.gov, NCT04711356.
Findings |
Between July 8 and Aug 18, 2021, 58 children were assessed for eligibility and 50 (27 aged 4–7 years and 23 aged 9–15 years) were enrolled and received an Ad26.ZEBOV booster vaccination, more than 3 years after receiving dose one of the Ad26.ZEBOV and MVA-BN-Filo vaccine regimen. The booster was well tolerated. The most common solicited local adverse event during the 7 days after vaccination was injection site pain, reported in 18 (36%, 95% CI 23–51) of 50 participants. The most common solicited systemic adverse event during the 7 days after vaccination was headache, reported in 11 (22%, 12–36) of 50 participants. Malaria was the most common unsolicited adverse event during the 28 days after vaccination, reported in 25 (50%, 36–64) of 50 participants. No serious adverse events were observed during the study period. 7 days after vaccination, the Ebola virus glycoprotein-specific IgG binding antibody geometric mean concentration was 28 561 ELISA units per mL (95% CI 20 255–40 272), which was 44 times higher than the geometric mean concentration before the booster dose. 21 days after vaccination, the geometric mean concentration reached 64 690 ELISA units per mL (95% CI 48 356–86 541), which was 101 times higher than the geometric mean concentration before the booster dose.
Interpretation |
A booster dose of Ad26.ZEBOV in children who had received the two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimen more than 3 years earlier was well tolerated and induced a rapid and robust increase in binding antibodies against Ebola virus. These findings could inform Ebola vaccination strategies in paediatric populations.
Funding |
Innovative Medicines Initiative 2 Joint Undertaking.
Translation |
For the French translation of the abstract see Supplementary Materials section.
Le texte complet de cet article est disponible en PDF.Plan
Vol 23 - N° 3
P. 352-360 - mars 2023 Retour au numéro
Article précédent
- Effect of systematic tuberculosis detection on mortality in young children with severe pneumonia in countries with high incidence of tuberculosis: a stepped-wedge cluster-randomised trial
- Olivier Marcy, Eric Wobudeya, Hélène Font, Aurélia Vessière, Chishala Chabala, Celso Khosa, Jean-Voisin Taguebue, Raoul Moh, Juliet Mwanga-Amumpaire, Manon Lounnas, Veronica Mulenga, Sandra Mavale, Josina Chilundo, Dalila Rego, Bwendo Nduna, Perfect Shankalala, Uzima Chirwa, Agathe De Lauzanne, Bunnet Dim, Emeline Tiogouo Ngouana, Madeleine Folquet Amorrissani, Lassina Cisse, Flore Amon Tanoh Dick, Eric A Komena, Sylvie Kwedi Nolna, Gerald Businge, Naome Natukunda, Saniata Cumbe, Prossy Mbekeka, Ang Kim, Chanrithea Kheang, Sokha Pol, Elizabeth Maleche-Obimbo, James A Seddon, Tan Eang Mao, Stephen M Graham, Christophe Delacourt, Laurence Borand, Maryline Bonnet, TB-Speed Pneumonia Study Group, Olivier Marcy, Angeline Serre, Anne Badrichani, Manoa Razafimanantsoa, Julien Poublan, Aurélia Vessière, Clémentine Roucher, Estelle Occelli, Aurélie Beuscart, Aurélie Charpin, Gemma Habiyambere, Salomé Mesnier, Eric Balestre, Bandana Bhatta, Anne-Laure Maillard, Joanna Orne-Gliemann, Emmanuelle Baillet, Nicolas Koskas, Marc D’Elbée, Delphine Gabillard, Hélène Font, Minh Huyen, Maryline Bonnet, Manon Lounnas, Hélène Espérou, Sandrine Couffin-Cadiergues, Alexis Kuppers, Benjamin Hamze, Laurence BORAND, Agathe de LAUZANNE, Bunnet DIM, Chanthy Keang, Long PRING, Song YIN, Channimol SARITH, Chanvirak PHAN, Sovann NHEUONG, Socheat LY, Sanary KAING, Vouchleang SRENG, Elen LUN, Leakhena SAY, Sophea SUOM, Romyka FERHY, Dina SO, Sorunna BORN, Sophea PAL, Boraneath NANG, Tan Eang MAO, Ang KIM, Viso Srey, Piseth Kan, leakhena Hout, Samnang Ith, Sophany Oum, Sokunvadhana Sau, Kim Heang Ho, Daronic Kith, Nathara Nuch, Chhun Leang Horm, Cheameas Sophon, Bosba Roeungdeth, Chhay MENG, Ravin RITH, Samnang PHY, Chanchetra SOR, Voleak SAO, Sophea KHAT, Bunthoeun MAK, Angkeaborin UY, Sreyny KHAY, Kimsan SOM, rongvirak HACH, Hay SOK, Sotheavy KUON, Synatt HENG, Amara SENG, Sopheak NIM, Reach PAN, Srean KIM, Keo SREY LEAP, Bormey NET, Viccheka NOUN, Daven LAY, Chhaing MANY, Socheata Seng, Vuthy Ly, Saran So, Sovutthik Oun, Sopheap CHEY, Rattany CHHEA, Lydeth BAONG, Vanna THOUNG, Chanrithea KHEANG, Borady BY, Vathanak Nguon, Eksophea MEACH, Sopheak Tek, Sina Ngeav, Tetra Lun, Deth HEM, Nayreang CHUT, Setha SARIK, Hgekkoung NANG, Mengnean MEACH, Sopal SRENG, Dara SAR, Rathana KIN, Phoran ROS, Chenda DORN, Chansy KAK, Srey Leak Sambath, Leakhena Son, Linda Bin, Eangnay Pengong, Sokha Pol, Samnang Khutsorn, Sorsophea Seang, Virak Soun, Vuthy Vong, Chandara Khoeung, Panha Um, Sokunthea Bou, Sarin Song Pich, Puthy Nim, Sopheak Khat, Nuon Ban Si, Sovannodom Ream, Sim Ing, Phanith Chann, Samrith Ngeth, Marina Sun, Sokea Chhoeung, Soeun Sean, Ratanak Prak, Jean-Voisin Taguebue, Sylvie Kwedi Nolna, Audrey Amboua Schouame Onambele, Numfor Hycenth, Bernard Melingui, Angeline Nkembe Medounmga, Luciole Hougnang Tatmi, Nathalie Etemgoua, Vanessa Kouesso, Jean Bugin, Celestine Nzedjom, Roger Ngoya, Jules Eyike, Elyse Loudjom, Roger Lonsti, Ladi Dang, Edward Bintar, Chantal Njayong, Cinthia Ngonsoa O, Isabelle Ndzeukap, Pascaline Dzoyem, Clémentine Dzokou, Berthe Dindo, Raoul Moh, Eric Auguste Komena, Roger Aka Bony, Christian Kouadio, Serge Danho, Melissa Goli, Madeleine Folquet, Max Valère Itchy, Abdel Sidibé, Lancina Cissé, Joseph Ouattara, Mamadou Konaté, Flore Amon-Tanoh Dick, Melissa Cardena, Laurence Adonis-Koffi, Djabia Eugenie, Ferdinand Kouamé, Hervé Menan, André Inwoley, Timothée Ouassa, Marcelle Sandrine Nguessan, Celso Khosa, Saniata Cumbe, Emelva Manhiça, Alcina Zitha, Valter Chiúle, Eva Muxanga, Irene Gune, Yara Lima, Jorge Ribeiro, Sandra Mavale, Josina Chilundo, Felismina Maxanguana, Natália Morais, Julieta Manhiça, Josefina Give, Jafito Atumane, Gelson Lucas, Arsénio Thai, Adélio Chave, Dalila Rego, Lúcia Guambe, Faiaz Issa, Rosa Carneiro, Neusa Pene, Natércia Florindo, Dália Machel, Cecília Cumbane, Helena Mendes, Mule Kitungwa, Valdo Muianga, Humberto Tamele, Adelino Sulude, Roda Mabota, Herquéria Comandante, Abelardo Massangaie, Eric Wobudeya, Gerald Bright Businge, Faith Namulinda, Robert Sserunjogi, Rashidah Nassozi, Charlotte Barungi, Hellen Aanyu, Doreen Muwonge, Eva Kagoya, Serene Aciparu, Sophia Chemutai, Samuel Ntambi, Amir Wasswa, Juliet Nangozi, Abner Tagoola, Prossy Mbekeka, Sajja Kenneth, John Paul Lubega, Aidah Nassali, Jessica Tagobera, Christine Agwang, Florence Kalembe, Annet Ajambo, Elizabeth Aguti, Samuel Kasibante, Henry Matende, Israel Owen Odongo, Juliet Mwanga Amumpaire, Naome Natukunda, Gertrude Ngabirano, Paul Kakwenza, Simpson Nuwamanya, Miria Nyangoma, Jane Nabbuto, Florence Abok, Rinah Arinaitwe, Diana Birungi, Evans Mwesigwa, Daniel Atwine, Hassan Mbega, Patrick Orikiriza, Ivan Taremwa, Esther Turyashemererwa, Hope Derrick, Dan Nyehangane, Rodney Kaitano, Susan Logoose, Steven Businge, Charles Ntambi, Jerome Mugabi, John Mzee, Julius Besigye, Saul Kanzira, Phionah Turyatemba, Florence Twebaze, Chishala Chabala, Veronica Mulenga, Perfect Shankalala, Chimuka Hambulo, Vincent Kapotwe, Marjory Ngambi, Kunda Kasakwa, Uzima Chirwa, Chifunda Kapula, Susan Zulu, Grace Nawakwi, Teddy Siasulingana, Jessy Chilonga, Maria Chimbini, Mutinta Chilanga, Bwendo Nduna, Muleya Inambao, Mwate Mwambazi, Barbra Halende, Wyclef Mumba, Endreen Mankunshe, Maureen Silavwe, Moses Chakopo, Roy Moono
- Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine–pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study
- Khalid B Beshir, Julian Muwanguzi, Johanna Nader, Raoul Mansukhani, Aliou Traore, Kadidja Gamougam, Sainey Ceesay, Thomas Bazie, Fassou Kolie, Mahaman M Lamine, Matt Cairns, Paul Snell, Susana Scott, Abdoulaye Diallo, Corinne S Merle, Jean Louis NDiaye, Lanto Razafindralambo, Diego Moroso, Jean-Bosco Ouedraogo, Issaka Zongo, Hamit Kessely, Daugla Doumagoum, Kalifa Bojang, Serign Ceesay, Kovana Loua, Hamma Maiga, Alassane Dicko, Issaka Sagara, Ibrahim M Laminou, Sonny Johnbull Ogboi, Tony Eloike, Paul Milligan, Colin J Sutherland
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?